vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and WESTWOOD HOLDINGS GROUP INC (WHG). Click either name above to swap in a different company.

LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $25.0M, roughly 1.2× WESTWOOD HOLDINGS GROUP INC). WESTWOOD HOLDINGS GROUP INC runs the higher net margin — 3.1% vs -32.1%, a 35.2% gap on every dollar of revenue. On growth, WESTWOOD HOLDINGS GROUP INC posted the faster year-over-year revenue change (7.4% vs -4.5%). Over the past eight quarters, WESTWOOD HOLDINGS GROUP INC's revenue compounded faster (4.9% CAGR vs -0.1%).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

Westwood Studios, Inc. was an American video game developer based in Las Vegas, Nevada. It was founded by Brett Sperry and Louis Castle in 1985 as Brelous Software, but got changed after 2 months into Westwood Associates and was renamed to Westwood Studios when Virgin Games bought the company in 1992. The company was bought by Electronic Arts alongside Virgin Interactive's North American operations in 1998. In January 2003, it was announced that Westwood, alongside Westwood Pacific, would be ...

LFCR vs WHG — Head-to-Head

Bigger by revenue
LFCR
LFCR
1.2× larger
LFCR
$31.1M
$25.0M
WHG
Growing faster (revenue YoY)
WHG
WHG
+11.8% gap
WHG
7.4%
-4.5%
LFCR
Higher net margin
WHG
WHG
35.2% more per $
WHG
3.1%
-32.1%
LFCR
Faster 2-yr revenue CAGR
WHG
WHG
Annualised
WHG
4.9%
-0.1%
LFCR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
LFCR
LFCR
WHG
WHG
Revenue
$31.1M
$25.0M
Net Profit
$-10.0M
$782.0K
Gross Margin
25.0%
Operating Margin
-9.9%
Net Margin
-32.1%
3.1%
Revenue YoY
-4.5%
7.4%
Net Profit YoY
-52.0%
EPS (diluted)
$-0.29
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
WHG
WHG
Q1 26
$25.0M
Q4 25
$27.1M
Q3 25
$31.1M
$24.3M
Q2 25
$23.1M
Q1 25
$35.2M
$23.3M
Q4 24
$32.6M
$46.5M
Q3 24
$24.7M
$23.7M
Q2 24
$22.7M
Net Profit
LFCR
LFCR
WHG
WHG
Q1 26
$782.0K
Q4 25
$1.8M
Q3 25
$-10.0M
$3.7M
Q2 25
$1.0M
Q1 25
$-14.8M
$478.0K
Q4 24
$-6.6M
$3.7M
Q3 24
$-16.2M
$-1.2M
Q2 24
$-378.0K
Gross Margin
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
Q3 25
25.0%
Q2 25
Q1 25
28.0%
Q4 24
34.0%
Q3 24
21.8%
Q2 24
Operating Margin
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
8.0%
Q3 25
-9.9%
8.3%
Q2 25
3.8%
Q1 25
-25.7%
-0.3%
Q4 24
-6.0%
10.0%
Q3 24
-46.9%
-2.1%
Q2 24
-18.4%
Net Margin
LFCR
LFCR
WHG
WHG
Q1 26
3.1%
Q4 25
6.8%
Q3 25
-32.1%
15.4%
Q2 25
4.5%
Q1 25
-42.0%
2.1%
Q4 24
-20.2%
14.5%
Q3 24
-65.7%
-5.0%
Q2 24
-1.7%
EPS (diluted)
LFCR
LFCR
WHG
WHG
Q1 26
$0.09
Q4 25
$0.21
Q3 25
$-0.29
$0.41
Q2 25
$0.12
Q1 25
$-0.47
$0.05
Q4 24
$-0.25
$0.45
Q3 24
$-0.53
$-0.15
Q2 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
WHG
WHG
Cash + ST InvestmentsLiquidity on hand
$18.9M
$23.4M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
$126.1M
Total Assets
$235.2M
$150.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
WHG
WHG
Q1 26
$23.4M
Q4 25
$47.7M
Q3 25
$18.9M
$41.3M
Q2 25
$35.2M
Q1 25
$5.4M
$29.1M
Q4 24
$9.5M
$46.5M
Q3 24
$48.3M
Q2 24
$44.1M
Total Debt
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Stockholders' Equity
LFCR
LFCR
WHG
WHG
Q1 26
$126.1M
Q4 25
$125.6M
Q3 25
$-10.5M
$123.9M
Q2 25
$122.4M
Q1 25
$2.2M
$121.4M
Q4 24
$15.4M
$120.3M
Q3 24
$-3.9M
$120.4M
Q2 24
$120.5M
Total Assets
LFCR
LFCR
WHG
WHG
Q1 26
$150.4M
Q4 25
$162.3M
Q3 25
$235.2M
$154.0M
Q2 25
$146.3M
Q1 25
$237.7M
$135.0M
Q4 24
$255.4M
$150.0M
Q3 24
$246.8M
$151.5M
Q2 24
$147.4M
Debt / Equity
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
WHG
WHG
Operating Cash FlowLast quarter
$1.8M
$-2.6M
Free Cash FlowOCF − Capex
$25.0K
FCF MarginFCF / Revenue
0.1%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
-3.28×
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
WHG
WHG
Q1 26
$-2.6M
Q4 25
$18.9M
Q3 25
$1.8M
$8.5M
Q2 25
$7.3M
Q1 25
$1.2M
$-4.9M
Q4 24
$-6.1M
$21.1M
Q3 24
$-613.0K
$529.0K
Q2 24
$3.6M
Free Cash Flow
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
$18.8M
Q3 25
$25.0K
$8.5M
Q2 25
Q1 25
$-4.3M
$-4.9M
Q4 24
$-8.6M
$21.0M
Q3 24
$-4.0M
$519.0K
Q2 24
$3.5M
FCF Margin
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
69.5%
Q3 25
0.1%
34.8%
Q2 25
Q1 25
-12.1%
-21.1%
Q4 24
-26.3%
45.2%
Q3 24
-16.3%
2.2%
Q2 24
15.6%
Capex Intensity
LFCR
LFCR
WHG
WHG
Q1 26
Q4 25
0.3%
Q3 25
5.6%
0.3%
Q2 25
0.0%
Q1 25
15.5%
0.0%
Q4 24
7.5%
0.2%
Q3 24
13.9%
0.0%
Q2 24
0.1%
Cash Conversion
LFCR
LFCR
WHG
WHG
Q1 26
-3.28×
Q4 25
10.29×
Q3 25
2.29×
Q2 25
7.08×
Q1 25
-10.25×
Q4 24
5.69×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

WHG
WHG

Asset-based$19.3M77%
Trust fees$5.3M21%

Related Comparisons